AMMAN— Jordanian pharmaceutical and medical
supplies industries have transitioned from local to global, supported by
advancements in quality and competitiveness over the past quarter of a century.
This strategic industry has positioned the Kingdom among the most advanced
nations in this field.
اضافة اعلان
Since assuming constitutional powers, His
Majesty King Abdullah has shown particular interest in the pharmaceutical and
medical supplies sector, especially pharmaceuticals. Under his leadership, this
sector has ascended to international prominence, opening new horizons for
Jordanian companies to transcend borders with high-quality competitive
products, Al-Ghad reported.
Dr. Fadi Al-Atrash, the representative of the
pharmaceutical and medical supplies sectors at the Jordan Chamber of Industry,
emphasized its vital role, highlighting its tangible successes and
developments. He affirmed the commitment to international standards and
competitiveness.
The sector has witnessed remarkable progress
over the years, achieving significant growth and offering high-quality products
accepted both locally and globally. This is attributed to innovation and
diligent efforts by industrial establishments.
During the COVID-19 pandemic, the sector
demonstrated its resilience, meeting the increased local demand for medical
supplies and exporting a portion of its production.
The sector's contribution to the Gross
Domestic Product (GDP) is substantial, reflecting its role in driving
sustainable development and enhancing the Kingdom's economy.
Employing nearly 10,000 workers, with 98
percent being Jordanians, the sector emphasizes the utilization of the local
workforce across various levels.
With over 70 production lines focusing on
generic branded drugs, the sector adheres to high international quality
standards, solidifying its position as a producer of guaranteed quality
medicines.
The pharmaceutical and medical supplies sector
comprises 151 facilities within the Kingdom, with registered capital totaling
approximately JD341 million. Additionally, there are 15 Jordanian factories
operating abroad.
Over the past two decades, Jordan's
pharmaceutical industry has transitioned from a local to a global industry,
backed by significant support from His Majesty, aiming for self-reliance,
global market openness, and ensuring the Kingdom's pharmaceutical security.
In 2023, the sector achieved a significant
leap in exports, reaching JD620 million, with products reaching over 77
countries worldwide.
The sector aims to increase exports to over
JD2.1 billion by 2033, enhance value-added to approximately JD1.7 billion,
increase employment to 16,000 workers, and attract investments totaling around
JD1.1 billion.
The Jordan Food and Drug Administration (JFDA)
also plays a crucial role in supporting and developing the pharmaceutical
industry through continuous monitoring, introducing modern regulations, and
enhancing industry standards.
Read more National news
Jordan News
.jpg)
.jpg)
